Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-012888
Filing Date
2022-03-31
Accepted
2022-03-31 07:07:48
Documents
2
Period of Report
2022-03-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1526
2 EX-24 DOCUMENT attachment1.htm EX-24 5075
  Complete submission text file 0000899243-22-012888.txt   7952
Mailing Address MILLENNIUM PHARMACEUTICALS, INC. 40 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Protopapas Anna (Reporting) CIK: 0001347582 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40671 | Film No.: 22789099

Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Issuer) CIK: 0001861560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations